Shijiazhuang Yiling Pharmaceutical Co., Ltd.
002603
Peringkat dalam Saham
#4184
Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and... Shijiazhuang Yiling Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of Chinese medicine primarily in China. It offers drugs for cardiovascular and cerebrovascular, respiratory, endocrine, neurological, digestive, immune, and urinary diseases, diabetes mellitus, oncology, sleep-improving, and anti-aging. The company also provides dietary supplements, disinfection products, personal protective equipment, as well as formula granules. Shijiazhuang Yiling Pharmaceutical Co., Ltd. was founded in 1992 and is based in Shijiazhuang, China.
Harga Saham
$2.29
Kapitalisasi Pasar
$3.83B
Perubahan (1 hari)
3.06%
Perubahan (1 tahun)
-6.38%
Negara
CN
Perdagangan Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Kategori
Healthcare
Laba untuk Shijiazhuang Yiling Pharmaceutical Co., Ltd. (002603)
Laba pada Jun 2026 TTM: $246.26M
Menurut laporan keuangan terbaru dari Shijiazhuang Yiling Pharmaceutical Co., Ltd., laba saat ini perusahaan adalah $246.26M. Pada tahun 2023, perusahaan memperoleh laba sebesar $237.93M, penurunan dibandingkan dengan laba tahun 2022 sebesar $403.11M. Laba yang ditampilkan di halaman ini adalah laba sebelum bunga dan pajak, atau disebut juga EBIT.
Riwayat laba untuk Shijiazhuang Yiling Pharmaceutical Co., Ltd. dari 2008 hingga 2026
Laba pada akhir setiap tahun
| Tahun | Laba | Mengubah |
|---|---|---|
| 2026 (TTM) | $246.26M | -324.63% |
| 2024 | $-109.63M | -146.08% |
| 2023 | $237.93M | -40.98% |
| 2022 | $403.11M | 64.90% |
| 2021 | $244.45M | 12.26% |
| 2020 | $217.75M | 114.19% |
| 2019 | $101.66M | -0.25% |
| 2018 | $101.91M | 3.87% |
| 2017 | $98.11M | 8.63% |
| 2016 | $90.32M | 17.44% |
| 2015 | $76.90M | 16.02% |
| 2014 | $66.28M | 38.96% |
| 2013 | $47.70M | 37.56% |
| 2012 | $34.68M | -58.95% |
| 2011 | $84.47M | 51.19% |
| 2010 | $55.87M | 7.65% |
| 2009 | $51.90M | 145.52% |
| 2008 | $21.14M | 0.00% |
Laba untuk perusahaan serupa atau pesaing
| Perusahaan | Laba | Perbedaan Laba | Negara |
|---|---|---|---|
| $1.35B | 448.16% |
US
|
|
| - | - |
SE
|
|
| - | - |
FR
|
|
| $26.37M | -89.29% |
US
|
|
| - | - |
IT
|
